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LSVT-LOUD® has been shown to improve phonatory quality in patients with PD.  
Previous studies have shown an increase in vowel space area following treatment, but questions 
remain regarding possible methodological issues in interaction with phonatory factors. This 
study addressed these questions by comparing multiple formant measurement methods and 
vowel space metrics.  Ten participants were recorded on two separate days before and after 
treatment.  Formants were measured using a human-guided reference (dubbed ‘HGIM’), LPC, 
and two forms of a cepstrally-liftered spectrum.  Multiple vowel space metrics including the 
vowel articulation index, F2i/F2u, area of the vowel quadrilateral, and vowel formant dispersion 
utilized both lax and corner vowels to explore vowel space changes.  Analysis revealed no 
significant change in vowel space following LSVT.  High variability in LPC with a fixed 
coefficient was noted.  These results do not support previous claims of increased vowel space but 
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The Effect of Formant Measurement Methods on Vowel Space in Patients with Parkinson’s 
Disease Before and After Voice Treatment 
Parkinson’s disease has a serious impact on society.  Lee Silverman Voice Treatment 
(LSVT) is known to improve phonatory quality and intelligibility.  Previous studies seeking to 
explain increased intelligibility in terms of improved articulation fail to take into account the 
effect of phonatory factors on measures of articulation, such as vowel space area.  This thesis 
will explain how phonatory factors influence acoustic measures of formants, and in turn vowel 
space, using a variety of formant measurement methods and vowel space area metrics. 
Parkinsonism refers to a group of disorder that are characterized by resting tremors, 
rigidity, akinesia, and postural instability (Darley, Aronson, & Brown, 1969; Yorkston, 
Beukelman, Strand, & Hakel, 2010).  It includes idiopathic Parkinson’s disease, secondary 
parkinsonism, and Parkinson’s plus-syndromes (Adams & Dykstra, 2009; Ben-Shlomo & 
Sieradzan, 1995; Duffy, 2013; Yorkston et al., 2010).  Idiopathic Parkinson’s disease (PD) has 
no known cause but is characterized by basal ganglia dysfunction related to the loss of 
dopamine-producing cells known as dopaminergic neurons (Duffy, 2013; Yorkston et al., 
2010).  Loss of these cells and consequent effects on basal ganglia dysfunction leads to 
involuntary movements as well as decreased amplitude and force of movements (Duffy, 
2013).  Secondary parkinsonisms are disorders that share the symptoms of PD but have a known 
cause such as strokes, toxic-metabolic conditions, certain infections, or repeated head trauma 
(Darley et al., 1969; Duffy, 2013; Yorkston et al., 2010).  Parkinson’s-plus syndromes have the 
same symptoms as PD but include other symptoms; examples of Parkinson’s-plus syndromes 
include multiple system atrophy, progressive supranuclear palsy (PSP), corticobasal 




this thesis is idiopathic Parkinson’s disease. 
Incidence and Impact on Society 
  In a review on the epidemiology of PD, de Lau and Breteler (2006) noted that 
“Parkinson’s disease (PD) is the second most common neurodegenerative after Alzheimer’s and 
is expected to impose an increasing social and economic burden on societies as populations age” 
(p. 525).  The incidence of PD rises with age, with an incidence of approximately 93.1 in 
100,000 people between the ages of 70 and 79 versus an incidence of 17.4 in 100,000 people 
between the ages of 50 and 59 (Lees, Hardy & Revesz, 2009).  Some studies indicate that men 
are at a greater risk of developing PD than women, though differences have been noted across 
studies (de Lau & Breteler, 2006; Lees et al., 2009).  Though age is considered a major risk 
factor, it should be noted that 10% of the people with PD are younger than 45 years of age (Lees 
et al., 2009).  The median age of onset is 60 years of age and the average duration of survival 
after diagnosis is 15 years (Duffy, 2013; Lees et al., 2009).  Among the most prominent features 
of PD is the marked change in speech and voice over the progression of the disease, which can 
have a profound impact on quality of life of patients living with PD. 
Hypokinetic Dysarthria and PD 
Hypokinetic dysarthria (HKD) is characterized by a decreased amplitude and force of 
speech movements (Adams & Dykstra, 2009; Duffy, 2013).  HKD is most often associated with 
PD and is estimated to occur in 60 to 80% of patients diagnosed with PD (Adams & Dykstra, 
2009; Duffy, 2013).  It affects all levels of speech, including respiration, phonation, resonance, 
and articulation, but can be especially detrimental to voice, articulation and prosody (Duffy, 
2013).   




the respiratory musculature, resulting in reduced vital capacity and amplitude of chest wall 
movements, as well as irregular breathing patterns (Adams & Dykstra, 2009; Duffy, 2013; Gentil 
& Pollak, 1995).  Numerous studies have found that the maximum sustained phonation of 
patients with PD was shorter than normal controls, though some studies did not find a significant 
difference between these groups (Adams & Dykstra, 2009; Canter, 1965; Duffy, 2013; Gentil & 
Pollak, 1995).  Adams and Dykstra (2009) suggested several reasons for this inconsistency, 
including differences severity level, symptoms profile, testing procedures, and amount of 
practice the participants received from study to study.  In addition to maximum sustained 
phonation, in his review of the literature Duffy (2013) found: 
…reduced airflow volume during vowel prolongation, fewer syllables per breath group, 
shorter utterance length, use of greater than average percentage of vital capacity per 
syllable, increased inspiratory duration during extemporaneous speech, and increased 
breath groups during reading have been documented in some patients with parkinsonisms 
and presumed hypokinetic dysarthria. (p. 175) 
Reduced respiratory capacity and efficiency can have a direct effect on phonation and perceptual 
features that are a hallmark of HKD as associated with PD. 
Changes in phonation.  One of the most common perceptual features of PD is reduced 
loudness.  The physical correlate of loudness, intensity, has been examined in many studies with 
varying results.  According to Adams and Dykstra (2009), some studies found a decrease in 
average intensity to corroborate a perceived decrease in loudness while other studies did not 
support this conclusion.   For example, Adams et al. (2006) found a decreased average intensity 
in conversational speech, sentence imitation, and maximum intensity.  On the other hand, Canter 




participants with PD and normal controls when they were instructed to repeat the syllable “no” at 
an “average” loudness level.  Interestingly, participants with PD demonstrated significantly 
lower SPL for the “loud” and “shouted” conditions.  In another study, Canter (1963) found no 
significant difference in mean peak SPL between participants with PD and normal controls 
during oral reading.  In a study by Dromey (2003), participants with PD differed significantly 
from normal controls in the vowel phonation task but not in the reading or monologue task.  In 
his review of the literature, Duffy (2013) stated that measures of intensity “generally document 
reduced vocal intensity” (p. 175).  Clearly, there are confounding factors such as the definition of 
average intensity and the effects of speech task on SPL.  It is also possible that intensity is not a 
perfect physical correlate of the perceptual feature loudness.  Additionally, it must be considered 
that the variation in physical results from perceptual observations may be due to the 
unnaturalness of the task or the environment in which the data is collected. 
 Though it is not a typically noted perceptual change, many studies have reported a higher 
fundamental frequency in participants with PD than normal controls (Adams & Dykstra, 2009; 
Canter, 1963; Duffy, 2013; Dromey, 2003).  Adams and Dykstra (2009) and Duffy (2013) in 
their reviews of HKD, also documented studies that found no change.  Interestingly, Dromey 
(2003) found a significant difference in fundamental frequency between participants with PD and 
age-matched neurologically normal controls only during the monologue task and not during the 
vowel phonation or reading task.  Overall, however, studies support the conclusion that patients 
with PD have a significantly higher F0 than normal controls but also that it may be task-specific. 
Changes in voice.  Changes in vocal quality is a prominent feature of HKD.  Dromey 
(2003) found a higher perceptual rating of dysphonia in patients with PD than in neurologically 




as more impaired than articulation.  In the same vein, Logemann, Fisher, Boshes, and Blonsky 
(1978) found that 89% of the PD patients in their sample were judged to have a laryngeal (voice) 
disorder, which was defined as any of the following: “breathiness, roughness, hoarseness, 
tremulousness, reduced pitch range, and a modal speaking pitch inappropriate to the patient’s age 
and sex” (p. 49).  Of the patients displaying a laryngeal dysfunction, 45% were judged to have a 
voice disorder in the absence of any articulatory deficit, while all but one patient with an 
articulation deficit was judged to have a co-occurring laryngeal dysfunction (Logemann et al., 
1978).  The vocal quality of patients with PD has often been described as breathy and harsh 
(Adams & Dykstra, 2009; Darley et al, 1969,).  In the study by Logemann et al. (1978), 45% of 
the patients were perceived as hoarse, 29% as rough, and 15% as breathy.   This discrepancy in 
perceptual judgement is likely due to the fact that the terms used to describe voice disorders are 
ill-defined and often vary from person to person and study to study.  Acoustic characteristics that 
correlate with perceived vocal qualities have proved elusive.  Some acoustic qualities that have 
been successfully ascribed to perceptual characteristics include the correlation between steeper 
spectral tilt and breathiness (de Krom, 1995), which has been observed in patients with PD 
(Dromey, 2003).  Elevated signal-to noise ratios has been correlated to both breathiness and 
roughness (de Krom, 1995) and has been inconsistently noted in acoustic studies of patients with 
PD (Adams & Dykstra, 2009).  
Changes in prosody.  Prosodic abnormalities that have been noted in the PD population 
include monopitch, monoloudness, reduced stress, short phrases, variable rate, and short rushes 
of speech (Adams & Dykstra, 2009; Darley et al., 1969; Gentil & Pollak, 1995; Kent & 
Rosenbeck, 1982).  Darkins, Fromkin, and Benson (1988) studied whether the aprosody noted in 




impairment by asking participants to differentiate between noun compounds (e.g. greenhouse) 
and noun phrases (e.g. green house) both receptively and expressively.  The subjects with PD did 
not differentiate between the two categories expressively, failing to distinguish between the two 
categories in terms of pause or pitch.  However, they did not differ from normal controls in terms 
of prosodic comprehension, suggesting that the prosodic abnormalities shown by patients with 
PD is the product of a disordered speech mechanism, rather than due to any kind of language 
impairment.  Acceleration of speech rate is one of the features that distinguishes HKD from the 
other dysarthrias.  Kent and Rosenbeck (1982) suggested that “the perception of ‘short rushes of 
speech’ or ‘accelerated speech’ might be based not so much on actual increases in the rate of 
articulatory events as on reductions in the range of articulatory movements” (p. 274).  This was 
first posited by Netsell, Daniel, and Celesia (1975), who attributed this undershoot to muscle 
rigidity, stating, “The speaker might excite the rigid musculature with normally timed neural 
control signals for voluntary movements…only to have the speech articulators fail to reach the 
necessary position for production of a particular speech sound before beginning the movement 
for the following sound” (p. 170).  Thus there appears to be an interplay between articulation and 
prosody.  Prosodic abnormalities are considered one of the most characteristic features of HKD 
associated with PD. 
Changes in articulation: Consonants.  Indistinct articulation has long been noted as a 
feature of PD.  Attempts to specify the acoustic and phonetic changes that lead to the perception 
has revealed a variety of factors.  The most prominent changes have been noted in consonants.  
Logemann et al. (1978) studied the phonemes in error and concluded that place and manner of 
obstruent consonants was affected while voicing was not.  Gentil and Pollak (1995) attributed 




articulators as a result of muscular rigidity that is an intrinsic feature of PD.  This is supported by 
previous studies that have found that loss of phonemic identity is due to incomplete closure of 
the articulators (Ackerman & Ziegler, 1991; Darley et al., 1969).  This is especially apparent in 
the spirantization of stops, where stop consonants are produced with increased frication (Adams 
& Dykstra, 2009; Canter, 1965; Kent & Rosenbeck, 1982; Logemann & Fisher, 1981).  
Logemann and Fisher (1981) found that the stop-plosives /k/ and /g/ were the most commonly 
misarticulated stop consonants, followed by /ʧ/ and /ʤ/, /p/ and /b/, and /t/ and /d/ respectively.  
Logemann et al. (1978) suggest that deterioration of speech and voice begins in the laryngeal 
area as hoarseness or breathiness and proceeds anteriorly, first affecting phonemes produced 
with the back of tongue, then anterior lingual placements and finally labial articulations.  This 
progression is supported by Logemann and Fisher’s (1981) later inventory of misarticulated 
phonemes with the exception of /t/ and /d/, which one would expect to be the third most 
commonly misarticulated pair.  It is possible, however, that the teeth act as an additional barrier 
to mask the reduced degree of closure achieved at the alveolar ridge.  Studies have also noted 
that fricatives have less frication energy as a result of less forceful or turbulent airflow, which 
also can be attributed to a reduced degree of closure (Adams & Dykstra, 2009; Logemann & 
Fisher, 1981).  Changes in articulation can be attributed to more than just changes in manner.  
Forrest, Weismer, and Turner (1988) found that PD patients had a longer voice onset time (VOT) 
compared to normal elderly controls.  VOT is the time between the burst, or initial opening of 
the articulators, of a voiced stop consonant and the onset of voicing.  Changes in VOT can result 
in distortion of the target phoneme.   
 Changes in articulation: Vowels.  Impairment of vowel articulation in hypokinetic 




consonants (Adams & Dykstra, 2009).  Similar to the issues experienced in consonant 
articulation, it has been posited that vowel articulation may be impaired due to articulatory 
undershoot (Skodda, Visser, & Schlegel, 2011). A general reduction in vowel space associated 
with PD has been noted (Adams & Dykstra, 2009) though effects may be subtle and have not 
been consistently documented in all patients with PD.  Various forms of vowel space have been 
used in an attempt to document this theorized reduction in vowel space with varying results 
(Sapir, Ramig, Spielman & Fox, 2010): vowel space metrics will be detailed further in 
Measuring Articulation: Vowel Space Area and Table 1 (see Appendix). Skodda et al. (2011) 
found a significant reduction in vowel space area in males with PD during sentence reading.  
Their study utilized triangular vowel space area (tVSA), calculated using the corner vowels /i/, 
/u/, and /ɑ/.  Sapir et al. (2010) developed the formant centralization ratio (FCR), which also uses 
the corner vowel /i/, /u/, and /ɑ/.  Their study found a significant reduction in FCR between 
participants with PD and age-matched normal controls; the study also found that FCR sensitively 
differentiated between dysarthric participants and healthy participants (Sapir et al., 2010).  The 
variability between studies may be due to methodological differences, but it should also be 
considered that a metric that is sensitive enough to detect PD’s subtle effects on vowel 
articulation has not yet been developed. 
 Most studies of vowel articulation have focused on the corner vowels /i/, /u/, and /ɑ/.  
Tjaden, Rivera, Wilding, and Turner (2005) examined changes in vowel space using the lax 
vowels /ɪ/, /ʊ/, and /ɛ/.  The study found no difference between participants with PD and 
neurologically normal controls when reading at their habitual rate (Tjaden et al., 2005).  This is 
not surprising considering these lax vowels require less tongue excursion than the corner vowels.  




reduced formant transitions in segments /aɪ/, /ijə/ and /ɪl/, which can affect the intelligibility of 
speech. 
Changes in intelligibility.  Decreases in intelligibility have been commonly reported in 
PD (Anand & Stepp, 2015; Cannito, Suiter, Beverly, Chorna, Wolf, & Pfeiffer, 2012; Cannito, 
Suiter, Wolf, Chorna, Beverly, & Watkins, 2008; Duffy, 2013; Neel, 2009).  According to a 10-
year review of patients with PD by Duffy (2013) at the Mayo Clinic, 79% of patients had 
reduced intelligibility.  Intelligibility has been found to worsen with the progression of PD 
(Anand & Stepp, 2015).  The various speech deficits associated with PD impact intelligibility to 
varying degrees, making it difficult to determine exactly what element would best be targeted by 
therapeutic intervention.  Anand and Stepp (2015) investigated the effect of monopitch on 
intelligibility.  They found that the impact of monopitch on intelligibility was variable, with a 
greater impact on participants with moderate dysarthria than mild or severe dysarthria.  Reduced 
loudness is a common complaint in PD, and many successful therapeutic interventions focus on 
increasing loudness.  Neel (2009) investigated whether simply increasing the intensity of the 
speech signal without any other acoustic changes was as effective as loud speech.  She found that 
amplified speech was significantly more intelligible than habitual speech; however loud speech, 
which is accompanied by other acoustic changes to the voice, was more intelligible than 
amplified speech. 
 Changes in vowel space area have also been implicated in changes in intelligibility.  
According to Weismer, Jeng, Laures, Kent, and Kent (2001), “The direction of the acoustic 
vowel space effect is logical because a relatively compressed space would suggest reduced 
acoustic contrast among vowels, with a loss in word distinctiveness in either single words or 




amyotrophic lateral sclerosis (ALS) and PD, Weismer et al. (2001) found that acoustic vowel 
space was highly correlated with single word and sentence intelligibility.  However, in the same 
study, Weismer et al. found that participants with ALS had a smaller vowel space but greater 
intelligibility at sentence level compared to participants with PD, suggesting that there is more 
than vowel space at play.  According to a review of the literature by Kim, Hasegawa-Johnson, 
and Perlman (2010), the strength of the relationship between vowel space area and intelligibility 
has ranged from 0 to 71% across studies of different speech impairments.  Neel (2008) found 
that vowel space area accounted for 9 to 12% of the variance in intelligibility in normal speakers.  
In their study of children with dysarthria, Higgins and Hodge (2002) found that vowel space area 
accounted for 53% of variance in single words and 41% of variance in sentences.  Turner, 
Tjaden, and Weismer (1995) found that vowel space area accounted for 45% of variance in 
intelligibility in speakers with ALS.  The effect of vowel space area on intelligibility in speakers 
with PD has also been investigated with vowel space area accounting for 6 to 46% of 
intelligibility (Tjaden & Wilding, 2004; Weismer, et al., 2001). In a study by McRae, Tjaden, 
and Schoonings (2002), vowel space area accounted for 13% of variance in perception of 
severity, with smaller vowel space area being associated with a greater perception of severity.  
These varying results suggest that vowel space area, like other aspects of speech, plays a role in 
intelligibility but is not the sole, or even most important component.  Turner, Tjaden, and 
Wilding (1995) suggest that perhaps vowel space area is more predictive of intelligibility in 
patients who are less than 70% intelligible, which may explain why the role of vowel space area 
varies between conditions and individuals.  Intelligibility is a complex, multifactorial feature and 




Treatments for Dysarthria Associated with Parkinson’s Disease 
 There are a variety of treatment options available for patients with PD suffering from 
speech and voice disorders.  According to Trail et al. (2005), “Current treatments for speech and 
voice disorders in people with PD consist of medical therapies, surgical procedures, behavioral 
speech therapy, or a combination thereof” (p. 208).  Medical and surgical interventions alone 
have been shown to have a limited effect on voice (Fox, Morrison, Ramig, & Sapir, 2002; 
Ramig, Fox, & Sapir, 2004; Trail et al., 2005; Yorkston & Beukelman, 2010). Trail et al. (2005) 
concluded in their review of current speech treatments for PD that “At this time, a combination 
of medical therapy (e.g., optimal medication) with behavioral speech therapy appears to offer the 
greatest improvement for speech dysfunction” (p. 208).  The following paragraphs provide a 
brief review of medical, surgical, and behavioral interventions for speech disorders associated 
with PD. 
Medical treatments.  One of the most common medical treatments for PD is the use of 
levodopa, which helps boost dopamine levels in the brain.  Though it has been shown to have 
positive effects for limb movement and function, it has a less significant effect on speech (Trail 
et al., 2005).  Biary, Pimental and Langenberg’s study (as cited in Trail et al., 2005) found that 
the use of clonazepam improved some aspects of speech including short rushes of speech, 
imprecise consonant and inappropriate silences.  However, their study showed little 
improvement in voice quality or low pitch.  Though medical treatments have some utility in 
improving speech and voice, medication alone is not effective. 
Surgical treatments.  Various surgical treatments have been used in the treatment of 
speech and voice disorders associated with PD.  Pallidotomy and thalamotomy are two common 




typically have no effect on speech or can actually lead to a decline in speech function (Farrell, 
Theodoros, Ward, Hall, & Silburn, 2005; Tarazi, Sahli, Wolny, & Mousa, 2014; Trail et al., 
2005).  The use of deep brain stimulation has been shown to improve motor symptoms but not 
speech and is often associated with worsening intelligibility (Tarazi et al., 2014; Trail et al., 
2005).  Collagen injection in the vocal folds temporarily improves hypophonia but has no effect 
on any other aspect of speech (Trail et al., 2005).  Overall, surgical treatment is most effective 
for the motor symptoms of PD and is not meant to be a speech intervention. 
Behavioral therapy.  Of all the intervention techniques, behavioral therapy has shown 
the most promise in treating speech and voice disorders associated with PD.  According to 
Adams and Dykstra (2009), the main points of focus of behavioral therapy are “(1) increasing 
speech intensity, (2) improving speech prosody (i.e., monotonous/monoloud speech), (3) 
reducing rapid speech, and (4) increasing articulatory mobility and precision” (p. 174).  A variety 
of strategies have been used to achieve these goals.  Ramig, Countryman, Thompson, and Horii 
(1995) studied the effect of increasing respiratory effort on reducing hypophonia.  Increase 
respiratory effort was targeted using maximum inhalation and exhalation tasks, maximum 
duration of voiceless continuants /s/ and /f/ and sustained intraoral pressure.  The participants 
showed improvements in some aspects of speech such as SPL during reading and perceptual self-
ratings of loudness in females, and pause duration during reading for male and female 
participants.  Dromey (2000) compared the effect of increasing vocal loudness versus 
hyperarticulation on lip kinematics in patients with PD.  His study found that both methods were 
effective in increasing lip displacements, intensity, and lip velocity, though the loudness therapy 
showed a greater increase in loudness and hyperarticulation therapy showed a greater increase in 




Biofeedback and prosthetic devices.  Biofeedback can be used during behavioral 
therapy to provide the patient with information about pitch variation, speech loudness, and 
speech rate.  Adams and Dykstra (2009) in their review of the use of biofeedback as part of 
behavioral therapy concluded that  
(1) improvement in the speech of PD patients can be achieved through biofeedback 
therapy, (2) these improvements can be measured in the clinical setting through the use of 
both perceptual and acoustic procedures, and (3) improvements achieved through 
behavioral therapy plus biofeedback are greater than improvements achieved with 
behavioral therapy alone.  (p. 176) 
They also concluded that little carryover occurs with the use of biofeedback, though it should be 
noted that there are currently few studies evaluating carryover following therapy using 
biofeedback. 
 The use of prosthetic devices in aiding carryover has been sparsely studied for patients 
with PD.  Adams and Dykstra (2009) suggest the use of a voice-activated masker to provide 
background noise for patients with hypophonia. Though this has not been studied, it is supported 
by a study by Adams et al. (2006) that found that patients with PD increase their loudness to 
compensate for background noise.  Other devices that have been shown to have some long-term 
success include the use of delayed auditory feedback (DAF), voice amplification devices, and 
pacing boards (Trail et al., 2005).  Pacing strategies such as pacing boards or finger tapping have 
been shown to slow rate while DAF has been shown to slow rate and improve intelligibility 
(Adams & Dykstra, 2009). 
Lee Silverman Voice Treatment (LSVT-LOUD®).  LSVT is currently considered the 




studied over the last two decades.  According to Fox et al. (2002), LSVT hinges on five 
concepts:  
(a) exclusive focus on voice (specifically vocal loudness), (b) stimulation of high-effort 
productions with multiple repetitions, (c) intensive delivery of treatment (4 individual 
sessions a week for 4 weeks, 16 sessions in one month), (d) enhancing sensory awareness 
of increased vocal loudness and effort (calibration), and (e) quantification of behaviors. 
(p. 112) 
Though pitch variability is also targeted, the primary therapeutic target is increased vocal 
loudness, which, according to Trail et al. (2005), “acts as a ‘trigger’ to increase vocal effort and 
coordination across the speech production system” (p. 213).  The program consists of intensive 
treatment for 50 to 60 min four times per week for one month.  Tasks completed during therapy 
include maximum sustained vowel phonation with a constant level of loudness and steadiness, 
and pitch exercises, including having the patient modulate their voice from their habitual pitch to 
their highest pitch as well as their habitual to lowest pitch.  Daily homework is also an important 
aspect of the program.  Though LSVT was designed for and is primarily used with PD, its use 
has been studied with other populations such as adults with ataxic dysarthria (Sapir et al., 2003), 
parkinsonian plus syndromes (Countryman, Ramig, & Pawlas, 1994), multiple sclerosis, aging 
voices, cerebellar ataxia (Fox, Ramig, Ciucci, Sapir, McFarland, & Farley, 2006) and children 
with cerebral palsy and Down syndrome (Fox et al., 2006).   
Therapeutic Changes Through LSVT 
 LSVT has been reported to produce global changes in speech and voice, meaning that the 
therapeutic targets have been shown to produce changes outside of the intended effects.  Though 




implicated as the primary impetus for changes in non-targeted areas. Changes have been noted in 
the areas of phonation, articulation, and prosody.  Some phonatory changes include 
improvements in SPL, voice quality, and vocal fold function, while articulatory improvements 
have largely been supported by increased vowel space.  Increased facial expression and 
improved intonation have also been noted (Fox et al., 2002; Fox et al., 2006).  In addition to 
communicative function, LSVT has also been shown to improve swallowing in dysphagic 
patients (Fox et al., 2002; Fox et al., 2006).   
How this carryover into various other oral and laryngeal functions takes place is not well 
understood.  In their paper outlining the LSVT approach and presenting preliminary efficacy 
data, Ramig, Bonitati, Lemke, and Horii (1994) stated that “Therapy techniques were designed to 
improve perceptual characteristics of voice by targeting the hypothesized underlying physical 
pathology” (p. 193).  Fox et al. (2002) expands on this concluding:  
…LSVT may affect speech production at two levels.  (a) Increased loudness can improve 
vocal fold closure and enhance the phonatory source, consistent with improving the 
carrier in the classic engineering concept of signal transmission...(b) Increased loudness 
may stimulate increased effort and coordination across the respiratory, laryngeal, and 
orofacial systems. (p. 114)  
The surprisingly widespread effects of this singular target have been the subject of a variety of 
studies exploring the effects of LSVT on respiration, phonation, articulation, intelligibility and 
prosody.  
Changes in respiration.  Improvements in respiration to support speech have been 
documented in various studies.  Though studies have not shown an increase in vital capacity, 




LSVT (Ramig et al., 1994; Ramig et al., 1995). This suggests improved control over and more 
efficient use of air flow following treatment.  This is supported by Ramig and Dromey’s (1996) 
study, which found increased subglottal air pressure and improved maximum flow declination 
rate.  Respiratory improvements provide a foundation for improved phonation. 
Changes in phonation.  Various changes have been noted in patients with HKD 
following treatment with LSVT including changes in SPL, fundamental frequency, and voice 
quality.  Increased loudness (of which SPL is the acoustic dimension) has been moderately 
supported both perceptually and acoustically.  Studies of perceptual ratings of loudness are not 
consistent with one another but overall suggest an improvement in loudness.  Ramig et al. (1994) 
found that participants rated themselves as having a significant increase in loudness while ratings 
by family members did not show a significant improvement in loudness.  Both familiar and 
unfamiliar clinicians, however, rated participants as having significantly improved loudness.  In 
contrast, Ramig et al. (1995) found only male participants rated themselves as having improved 
in loudness, while in an assessment completed by the family, both male and female participants 
were rated as having improved loudness.  Acoustic studies have shown increased SPL as 
measured in decibels (dB) across tasks including sustained vowel phonation (Cannito et al., 
2012; Ramig et al., 1995), reading and conversation (Ramig et al., 1995).  The difference 
between perceptual increases in loudness versus acoustic increases in intensity may at first cast 
doubt on whether the measured acoustic changes reach beyond statistical significance into 
clinical significance.  However, this issue echoes the ambiguous results of studies into decreased 
loudness/intensity in patients with PD discussed previously (see Hypokinetic Dysarthria and PD: 
Changes in Phonation), reinforcing the idea that perception of loudness is a multifaceted issue 




loudness ratings may also play a part in these variable results.  
Fundamental frequency has also shown improvement over the course of treatment, both 
in terms of mean and habitual fundamental frequency as well as fundamental frequency 
variability and range.  Ramig et al. (1994) found that participants showed improved mean 
fundamental frequency only during reading, while a study by Ramig et al. (1995) found 
increased habitual fundamental frequency across all tasks, including sustained phonation, 
reading, and monologue.  Ramig et al. (1994) also noted an increase in maximum fundamental 
frequency range as was as fundamental frequency variability during reading.  This was supported 
by a later study by Ramig et al. (1995) that also showed increased variability during reading and 
monologue. 
Voice quality, a prominent feature in patients with PD, has been examined both 
perceptually and acoustically before and after treatment.  Ramig et al. (1995) found an 
improvement in self-ratings of hoarseness in participants following treatment.  Cannito et al. 
(2006) examined the acoustic correlates of voice quality and observed changes from pre to post 
therapy.  Their study found a decrease in harmonic amplitude differences as a result of an 
increase in the second harmonic (H2), first formant (F1), second formant (F2), and third formant 
(F3).  Energy in the upper harmonics, which was reduced prior to treatment, increased.  Taken 
together, these results indicate an improvement in spectral tilt (i.e., reduced tilt), supporting a 
perceptual decrease in breathiness.  This is supported by visualization of improved true vocal 
fold closure seen on videostroboscopy (Smith, Ramig, Dromey, Perez, & Samandari, 1994).   
Changes in intelligibility.  Of practical interest are changes in intelligibility that take 
place in the course of treatment.  Subjective results include ratings of intelligibility by the 




varied, evidence suggests a significant increase in intelligibility as judged by family members, 
familiar and unfamiliar clinicians, and the participants themselves (Ramig et al., 1994; Ramig et 
al., 1995). Objective measures of intelligibility have also been utilized.  In a study of a single 
speaker, Cannito et al. (2008) found a statistically significant increase in the percentage of words 
understood by unfamiliar listeners from pre to post LSVT.  This study was later replicated by 
Cannito et al. (2012) with a larger group of participants; six out of the eight participants 
demonstrated statistically significant improvements in intelligibility as measured using 
percentage of understood words.  These results are especially noteworthy since both studies by 
Cannito et al. (2008) and Cannito et al. (2012) are somewhat biased against improved 
intelligibility because of the introduction of pink noise during listening task.   
Intrinsically connected to intelligibility is articulation.  Improvements in articulation have 
been observed using acoustic measures, including improved formant transition duration, rate, and 
extent as well as increased vowel space (Fox et al., 2002; Fox et al., 2006).  Increased amplitude 
of movement of the articulators has also been noted (Ramig et al., 2004). Vowel articulation has 
been of particular interest in the literature.  Increased vowel space has been implicated as an 
indicator of increased tongue movement and thus improved articulation.  Sapir et al. (2010) 
analyzed changes in vowel space using the vowel articulation index (VAI), logarithmically 
scaled vowel space area (lnVSA), formant centralization ratio (FCR) and the ratio of the second 
formant of /i/ to the second formant of /u/ (F2i/F2u).  In their study, they found that all measures 
showed significant improvement over the course of treatment, but FCR and F2i/F2u showed the 
most significant changes.  The next section explores the different kinds of vowel space area 




Measuring Articulation: Vowel Space Area 
There are many different ways to measure vowel articulation, each with benefits and 
drawbacks.  One common way of measuring improvements in vowel articulation is area of the 
vowel space.  Vowel space maps the geometric space created by the first and second formant (F1 
and F2, respectively) in different vowels.  F1 and F2 are related to tongue placement, with F1 
decreasing as tongue height increases and F2 increasing as tongue advancement increases.  
Measures of vowel space commonly use the corner vowels /i/, /u/, /ɑ/ and /æ/, which 
theoretically encompass F1 and F2 extremes.  Vowel space in dysarthric patients has been 
measured in a variety of ways, including triangular vowel space area (tVSA) (Sapir et al., 2010; 
Skodda et al., 2011), the area of the vowel quadrilateral (Higgins & Hodge, 2002), vowel 
articulation index (VAI) (Skodda et al., 2011), the formant centralization ratio (FCR) (Sapir et 
al., 2010) and the Tjaden method (McRae et al., 2002; Tjaden & Wilding, 2004).  Each of these 
methods varies in which vowels and formants they utilize, as well as their efficacy in measuring 
changes in vowel articulation in patients with PD (see Table 1 in Appendix for details).   
Skodda et al. (2011) found that VAI was better suited to detect impaired vowel 
articulation in the PD population than tVSA.  Sapir et al. (2010) created the formant 
centralization ratio (FCR) to measure changes in vowels articulation specifically for the PD 
population.  In their study, FCR was found to differentiate between dysarthric and healthy speech 
more successfully in comparison with other measures of vowel space, including VSA and 
lnVSA.  VAI and FCR, developed independently, are in fact inverses of each other and therefore 
can be considered identical.  This fact is supported by the similar results reported by Skodda et 
al. (2011) and Sapir et al. (2010) that show that VAI and FCR are better suited to detect vowel 




In their study of intelligibility in normal speakers, Bradlow, Torretta, and Pisoni (1996) 
found that although tVSA was larger in the most intelligible speaker versus the least intelligible 
speaker, there was no correlation between tVSA and intelligibility.  Rather, they found that 
vowel space dispersion (VSD) showed moderate correlation with intelligibility, suggesting that 
VSD may be a more reliable measure of intelligibility than tVSA.  VSD is derived by first 
calculating the center point in the vowel space by averaging all tokens of F1 (F1avg) and all 
tokens of F2 (F2avg) such that the center point equals (F2avg, F1avg).  The vector length (the 
distance from the vowel to the midpoint) is then calculated, and these distances are averaged 
together to obtain an overall VSD.  Karlsson and van Doorn (2012) proposed a similar metric, 
vowel formant dispersion (VFD).  VFD utilizes a weighted midpoint, and the resulting distances 
are not averaged into a single metric.  Rather, the distances of each vowel are plotted and 
considered individually, making this a descriptive if somewhat unwieldy metric.  In contrast to 
many other vowel space metrics, VSD and VFD can be adapted to consider vowels besides the 
corner vowels /i/, /u/, /ɑ/ and /æ/, allowing for a more complete picture of the vowel space.  
Though these metrics have not been well-studied in disordered populations, they appear worth 
considering the richness of the data they can potentially yield. 
In addition to varied ways of measuring vowel space, various materials have been used to 
elicit vowels for analysis.  Materials commonly used in previous literature include read sentences 
(Cannito et al., 2006; Sapir et al., 2007; Sapir et al., 2010), read narrative passages (McRae et al, 
2002; Tjaden & Wilding, 2004) and single words in isolation (Higgins & Hodge, 2002).  
Connected speech yields more naturalistic results than sustained phonation or single words and is 
thus more desirable for drawing conclusions that can be safely generalized.  However, 




context and are prone to prosodic variations that make them difficult to analyze.  Read passages 
and sentences provide a compromise between consistency and utility.  Sentences and passages 
are still subject to prosodic variation, but uniformity between participants is more likely since all 
participants read the same material.   
Though vowel space area has been used in previous studies to draw conclusions about 
changes in articulation following LSVT, there are variety of factors that require further 
exploration. It has been hypothesized that changes in vowel articulation can be attributed to 
improvements tongue placement, particularly in amplitude of movement.  Vowel space has 
typically been attributed to changes in articulation, but phonatory factors may interact with 
formant determination such that changes in phonation and articulation are confounded.  Since 
there are well-reported changes in vocal quality following LSVT, this is a potentially important 
consideration. The remainder of this chapter will review these issues in more detail by grouping 
them in two areas of consideration: phonatory factors and challenges of formant measurement. 
Phonatory Factors and Vowel Articulation 
First there is the interaction between phonatory factors and vowel articulation.  In a study 
involving patients with idiopathic Parkinson’s disease, Neel (2009) found that amplified 
dysarthric speech was more intelligible than unamplified dysarthric speech, suggesting that the 
articulated target was close enough to the correct category to be recognized when the speech 
signal was amplified.  She also found that loud speech was more intelligible than amplified 
speech, suggesting that there are factors intrinsic to loud speech other than increased amplitude. 
While improved tongue placement has been a commonly suggested factor, Neel also proposed 
that decreased spectral tilt during the loud condition contributed to improved articulation.  Steep 




feature of parkinsonian voice and hypokinetic dysarthria (HKD).  A decrease in spectral tilt—
that is, a return to a more typical spectral configuration—indicates an improvement in the 
contribution of voice to intelligibility with no particular effect on tongue placement. 
Changes in bandwidth could also account for improvement in the perception of vowel 
quality.  Breathy vocal quality is associated with increased bandwidth (Hixon, Weismer, & Hoit, 
2008).  According to Hixon et al. (2008), “When speech synthesizers are used to systematically 
increase the bandwidth of vowel formants while maintaining constant formant frequencies, 
listeners do not hear a change in vowel category.  Rather, vowels are perceived as increasingly 
‘muffled’” (p. 379). This calls into question precisely what perceptual studies of vowel 
articulation are measuring.  In their study, Sapir et al. (2007) rated changes in “vowel goodness” 
from pre to post LSVT in patients with idiopathic Parkinson’s disease, where “vowel goodness” 
was defined as “how well an uttered vowel is judged as an exceptionally good instance, or best 
exemplar, of an intended vowel” (p. 902).  Though patients who underwent LSVT showed 
improvements in “vowel goodness,” this metric failed to differentiate between changes in vowel 
category and vowel quality due to improvements in vocal quality (i.e., reduced breathiness). 
Challenges of Formant Measurement 
Since most measures of vowel articulation rely on formants, methods of formant 
measurement are another challenge which must be considered.  Many studies use linear 
predictive coding (LPC) to extract formant frequencies, which can be prone to error given certain 
conditions.  According to Vallabha and Tuller (2000), large bandwidth can cause errors in root-
solving, which is integral to LPC’s estimation of formants.  This is a particular concern for 
analyzing breathy voices, a hallmark of HKD.  Large bandwidth can also cause problems when 




low back vowels (where F1 is high and close to F2).  This could be problematic for vowel space 
measures, since most rely on the corner vowels /i/ (high front) and/or /ɑ/ (low back). 
The filter order is also important to consider in LPC.  Many studies utilize a standardized 
choice of filter order, which may not be appropriate for all voices or all vowels.  For example, 
back vowels, such as /u/ and /ɑ/ often need a higher order filter than front vowels (Vallabha & 
Tuller, 2000).  Since both of these vowels are often used in calculating VSA, incorrect estimation 
of their formant frequencies can cause over- or under-estimation of VSA.  An inappropriately 
high filter order can cause the appearance of false formants, while an inappropriately low filter 
order can smooth the spectrum, causing two formants to merge, creating a false formant that is in 
fact the average of two formants.  According to Vallabha and Tuller (2000), it may be necessary 
to choose a different filter order for each person and each vowel, using the visual of the spectrum 
to determine the appropriateness of the filter order. 
Finally, the basic assumptions of LPC are violated in breathy voices.  LPC models 
assume resonances only and not anti-resonances (Kent & Read, 2002).  Anti-resonances are 
created by a resonator off the main resonator (as in a nasal such as /n/) or behind the source.  In 
breathy voices, the incomplete closure of the vocal folds results in an additional resonator: the 
subglottal space.  This introduces anti-resonances into the voice.  Such a violation calls into 
question the validity of LPC in breathy voices, and it also introduces an increase in the 
bandwidth of F1 (Hanson, 1997). 
In an effort to address these issues, four formant measurement methods were used to 
understand if and to what degree these different methods are affected by phonatory qualities.  
These methods were LPC with a fixed coefficient (LPCf), cepstrally-liftered spectrum (ceps), 




2015) and human-guided interactive mode (HGIM).  HGIM utilized the spectrum, the LPC 
adjusted to conform to the spectrum, and a wide-band view of the spectrogram to locate the 
center of F1 and F2. A variety of methods were used to compute vowel space, including: VAI 
(Skodda et al., 2011), F2i/F2u (Sapir et al., 2007; Sapir et al., 2010), VFD (Karlsson & van 
Doorn, 2012) calculated using the corner vowels (VFDc) and VFD calculated using corner and 
lax vowels /i/, /u/, /ʌ/, /ɛ/, /æ/, and /ɑ/ (VFDa).  The cepstrally-liftered spectrum was of interest 
since it theoretically separates the source from the filter, therefore eliminating phonatory effects 
on the formant measures (Story & Bunton, 2015).  Formants extracted using LPCf, ceps, S-B and 
HGIM were used to compute each vowel space.  
The primary research question of this thesis addresses the possibility that observed 
increases in vowel space area associated with LSVT therapy are confounded with the known 
improvements in phonatory quality.  As a working hypothesis, it is presumed that LSVT does 
result in an increase in vowel space.  This was assessed using a number of methods to explore 
whether this increase is artefactual.  Results from the LPCf and spectrum smoothed by cepstral 
liftering were compared to HGIM. If LPC were vulnerable to phonatory factors, then the LPC 
based formant values are expected to be more variable across samples particularly in the pre 
sessions when phonation is less robust.  The formants extracted using the ceps and S-B are 
expected to be closer to the HGIM because the confounding effects of the harmonics have been 
removed.  Vowel space areas resulting from each method were inspected for purported increase 
effects post treatment.  
Secondarily, this thesis explored a variety of vowel space area metrics. VAI and F2i/F2u 
were used in the interest of replicating previous studies of changes in vowel space following 




common appearance in the literature than FCR.  VFDc and VFDa were included because of their 
ability to track changes in individual vowels and incorporation of multiple tokens of the same 
vowel.  VFDa in particular was used to observe how lax vowels are affected by LSVT, which 
has not been studied. 
Method 
Participants  
These data were obtained from a data set that was recorded in a larger study for the 
Michael J. Fox Foundation for Parkinson’s Research.  The first 10 subjects in sequence were 
used for this study.  Participants (age range 45-80 years) diagnosed with IPD and moderate to 
severe hypophonia were recruited.  Diagnosis was determined by a neurologist.  Efforts were 
made to recruit an equal number of male and female participants.  Efforts were made to 
distribute patients ethnically and racially in a distribution that is consistent with the 
demographics of the Memphis area (62% African American or black, 34% white, 2% Asian, 1% 
American Indian/Alaska Native, remaining 1% other race or races; 97% not Hispanic, 3% 
Hispanic).  Participants were optimally medicated.  All participants were evaluated using the 
Hoehn and Yahr Scale (1967) and the Unified Parkinson Disease Rating Scale (UPDRS).  As 
part of the measures for the larger study, other screening measures that were carried out included 
a hearing screening, Edinburgh handedness inventory (Oldfield, 1971), mini-mental status 
examination (Folstein, Folstein, & McHugh, 1975), and Beck Depression Inventory (Steer, Beck, 
& Garrison, 1986).  Only participants with no or mild cognitive impairment or depression were 
included.  All participants underwent an ENT screening and vocal fold examination; participants 
with evidence of structural abnormalities or vocal fold hyperfunction were excluded.  See Table 





All participants received LSVT for one hour, four times per week for four weeks.  Face-
to-face therapy was administered by a speech language pathologist licensed by the American 
Speech-Language Hearing Association (ASHA) and certified in LSVT.  During the first week, 
therapy consisted of four face-to-face sessions.  During the second, third, and fourth weeks, the 
participants completed two of the four therapy days per week using the LSVT Companion.  
Therapy supported by the LSVT Companion has been found yield similar results as traditional 
face-to-face therapy (Halpern et al., 2012).  It should be noted that some participants also 
received transcranial magnetic stimulation (TMS) as part of a larger study studying the effect of 
pairing TMS with LSVT.   
Procedures and Data Collection 
 Recording sessions were conducted on six different days.  Two took place before 
treatment (PRE1 and PRE2), two took place after treatment was completed (POST1 and POST2) 
and two were completed three months after the conclusion of therapy (FU1 and FU2).  The two 
sessions for the pre-, post-, and follow-up conditions took place within a week of each other.  As 
part of a larger assessment protocol, carrier phrases (“Say ___ again”) were used in accordance 
with previous studies of acoustic features (Cannito et al., 2006, Hanson, 1997).  The CVC 
syllables /bVd/, /gVd/, /dVd/, and /wVd/ were used with the vowels /i/, /u/, /ʌ/, /ɛ/, /æ/, and /ɑ/ 
and each carrier phrase was repeated four times. 
 Participants were instructed verbally and provided with written phrases.  All words were 
read to them prior to recording in order to ensure correct pronunciation.  If the participant 
mispronounced a word during recording, the word was repeated for them.  All recordings were 




mic to mouth distance calibrated for a flattened response.  Recordings were digitized at a 
sampling rate of 50 kHz1 using Kay Pentax Computer Speech Laboratory (CSL Model 4500).  
The intensity of the speech signals was measured and recorded using a Radio Shack sound level 
meter (Catalog no. 33-2055) at 30 cm. 
Data Analysis 
 Only the /b/ tokens were considered in this study.  The selection of only one phonetic 
context was justified by the fact that phonetic context has not been shown to impact vowel 
formants (Schouten & Pols, 1979).  The /b/ tokens were chosen in order to minimize potential 
coarticulation effects.  The first two correctly pronounced tokens of each vowel were used for 
analysis.  This was to minimize the effects of fatigue due to repetition and provide the “best 
exemplars” of each token.  Data from PRE1, PRE2, POST1, and POST2 were analyzed to get a 
richer sample of variation over time.  Data was analyzed using a customized version of the 
software program TF-32 (Milenkovic, 2016).  A zoom level of approximately 500 ms and a 
bandwidth of 400 Hz was used to optimize formant visualization.  Given the dialectical variation 
of some participants, the portion of the vowel that best represented the target vowel was 
determined auditorily.  For example, diphthongization, a common feature of Southern English, 
renders some productions of /bɛd/ as /bejɛd/.  Therefore, only the portion which matches the 
target vowel auditorily were used.  In cases where no auditory difference could be determined 
1One session (POST1 for Subject 1) was found to be recorded at a sampling rate of 44 kHz. 
due to the brevity of the segment or insufficiently dramatic formant shifts, the portion where the 
location of the formants best represented the theoretical expectations of the target vowel was 
chosen.  For example, the steady state where F1 and F2 were the lowest would have been 
selected for the target vowel /u/.  F1 and F2 were determined using four methods: HGIM, LPCf, 




replicate previous studies. 
The formants were used to compute the area of the vowel quadrilateral (Higgins & 
Hodge, 2002), F2i/F2u (Sapir et al., 2007; Sapir et al., 2010), VAI (Skodda et al., 2011), VFDc, 
and VFDa, based on VFD by Karlsson and van Doorn (2012).  These measures, with the 
exception of VFDa and VFDc, have been chosen in order to compare the results of this study 
with previous studies.  VFDa and VFDc were included to determine changes in individual 
vowels and to assess the appropriateness of these metrics in dysarthric speech, which has not yet 
been explored. 
Results 
 Before proceeding to presentation of results, this section begins with a review of the 
study purposes in terms of measurement strategies and vowel space metrics.  The research 
questions of this study involved an attempt to replicate the study by Sapir et al. (2010), which 
showed an increase in vowel space from pre to post LSVT.  Human-guided interactive mode 
(HGIM) was used as the gold standard of this study against which the validity of other formant 
measurement approaches could be assessed.  Considering the possibility that measurement issues 
conspired with phonatory factors to create a confound for Sapir et al.’s methods, LPC with a 
fixed coefficient (LPCf) was used as a basis of comparison.  Minor adjustments to the LPC 
coefficient were made by Sapir et al. (J. Spielman, personal communication, June 1, 2016); 
however, of the formant measurement methods employed in this study, LPCf afforded the best 
opportunity to assess the phonatory confound question and most closely approximated the 
methods of Sapir et al.  The cepstrally-liftered spectrum methods, ceps and S-B, were intended as 
exploratory measures to assess the appropriateness of these methods for use with dysarthric adult 




& Bunton, 2015, Story & Bunton, 2015, May).   
A variety of vowel space metrics were considered as well.  The vowel articulation index 
(VAI) and F2i/F2u were selected for comparison with Sapir et al.’s (2010) previous study.  
Though that study used the formant centralization ratio (FCR), VAI (simply the inverse of FCR) 
was deemed an equivalent metric and is more commonly found in subsequent literature 
concerning vowel space assessments in the PD population (Rusz et al., 2013; Spielman et al., 
2011).  The area of the vowel quadrilateral (Higgins & Hodge, 2012) was selected as a standard 
measure of VSA and because of its inclusion of all four corner vowels, /i/, /u/, /æ/, and /ɑ/.  The 
vowel formant dispersion (VFD) (Karlsson & van Doorn, 2012) calculated using the four corner 
vowels /i/, /u/, /æ/, and /ɑ/ (VFDc) was examined for its ability to incorporate multiple tokens of 
each vowel.  Similarly, VFD (Karlsson & van Doorn, 2012) calculated using /i/, /u/, /ʌ/, /ɛ/, /æ/, 
and /ɑ/ (VFDa) was examined for its ability to incorporate multiple tokens of each vowel as 
while as its use of a wider variety of vowels.  Vector lengths had not typically been combined 
into a single metric by the developers of this method (F. Karlsson, personal communication, May 
31, 2016), therefore, VFDc and VFDa were utilized in two ways.  First, the average vector length 
of all the vowels was calculated to determine whether the average vector length increased from 
pre to post treatment.  Secondly, the vector lengths of the individual vowels were compared pre 
to post treatment to determine if there were any changes in the individual vowels. 
Reliability of formant measures was assessed by having another rater reanalyze 20% of 
the formant measures for all formant measurement methods (HGIM, LPCf, ceps, and S-B).  An 
attempt was made to distribute the reanalyzed samples evenly across participants, pre or post 
sessions, and vowels.  Highest priority was given to distribution across participants.  Distribution 




the lowest priority.  A Pearson product moment correlation was performed on all data.  For 
HGIM, the correlation coefficient was 0.93 for F1 and 0.96 for F2.  For LPCf, the correlation 
coefficient 0.93 for F1 and 0.90 for F2.  For ceps, the correlation coefficient was 0.80 for F1 and 
0.94 for F2.  For S-B, the correlation coefficient was 0.89 for F1 and 0.96 for F2.  The average 
difference between raters was computed by calculating the difference between each formant 
measure and averaging the differences.  For HGIM, the average difference was -20.88 Hz for F1 
and -15.70 Hz for F2.  For LPCf, the average difference was 5.70 Hz for F1 and -3.18 Hz for F2.  
For ceps, the average difference was 6.21 Hz for F1 and -56.50 Hz for F2.  For S-B, the average 
difference was 2.49 Hz for F1 and -45.18 Hz for F2.  The standard error of these differences was 
computed for all data.  For HGIM, the standard error was 5.95 Hz for F1 and 13.16 Hz for F2.  
For LPCf, the standard error was 5.28 Hz for F1 and 21.85 Hz for F2.  For ceps, the standard 
error was 9.37 Hz for F1 and 17.53 Hz for F2.  For S-B, the standard error was 7.22 Hz for F1 
and 14.12 Hz for F2.  Reliability measure results are summarized in Table 3 in Appendix. 
 Repeated measures analysis might have been appropriate for a larger number of 
observations (as cited in Sapir et al. 2010); however, due to the size of the available pool for this 
study, the VSA metrics yielded only 10 observations per session.  Visual inspection revealed 
high variability across trials, regardless of formant measurement method, and treatment effects 
were not substantially greater than trial variability.  It appeared, therefore, that statistical analysis 
was inappropriate for this data set so results will currently be examined graphically and 
numerically.  Figures1 through 5 in Appendix show trial and treatment results, with each 
numerated figure depicting the results from one vowel space metric.  Within each numerated 
figure, each lettered set represents a given formant measurement method.  Three graphs appear 




treatment effects depicted as the differences between pre and post averages.   
Graphical Presentation of Findings 
VAI.  VAI, utilized by Sapir et al. (2010), was calculated using the formant measurement 
methods HGIM, LPCf, ceps, and S-B.  The graphical results by subject are presented in Figure 
1a through 1d in Appendix, with the lettered set representing the different formant measurement 
methods.  Visual inspection across treatment revealed no consistent increase or decrease in VAI.  
By visual inspection of the data, treatment effects did not appear to be any larger than trial-to-
trial variability.  Individual increases or decreases across treatment did not appear to exceed 
increases or decreases across trials.   
F2i/F2u.  F2i/F2u, utilized by Sapir et al. (2010), was calculated using the formant 
measurement methods HGIM, LPCf, ceps, and S-B.  The graphical results by subject are 
presented in Figure 2a through 2d in Appendix, with the lettered set representing the different 
formant measurement methods.  Visual inspection across treatment revealed no consistent 
increase or decrease in F2i/F2u.  By visual inspection of the data, treatment effects did not 
appear to be any larger than trial-to-trial variability.  Individual increases or decreases across 
treatment did not appear to exceed increases or decreases across trials.   
Area of the vowel quadrilateral.  The area of the vowel quadrilateral, which includes 
the four corner vowels /i/, /u/, /æ/, and /ɑ/, was calculated using the formant measurement 
methods HGIM, LPCf, ceps, and S-B.  The graphical results by subject are presented in Figure 
3a through 3d in Appendix, with the lettered set representing the different formant measurement 
methods.  Visual inspection revealed no general trend of increase or decrease across treatment.  
By visual inspection of the data, treatment effects did not appear to be any larger than trial-to-




increases or decreases across trials.   
VFDa.  The vector lengths for each of the vowels /i/, /u/, /ʌ/, /ɛ/, /æ/, and /ɑ/ were 
calculated using the formant measurement methods HGIM, LPCf, ceps, and S-B.  These lengths 
were then averaged to yield an average vector length for the vowel space for each trial, PRE1, 
PRE2, POST1, and POST2.  These values were then graphed in the same manner described 
above.  The graphical results by subject are presented in Figure 4a through 4d in Appendix, with 
the lettered set representing the different formant measurement methods.  Visual inspection 
revealed no general trend of increase or decrease across treatment.  By visual inspection of the 
data, treatment effects did not appear to be any larger than trial-to-trial variability.  Individual 
increases or decreases across treatment did not appear to exceed increases or decreases across 
trials. 
To determine whether there was any significant change in the vowels that was not 
reflected in the average of the vectors, the individual vowel vector lengths yielded by HGIM 
were also examined.  For each vowel, the vector lengths observed in the pre-treatment sessions 
were compared graphically to those of the post-treatment sessions.  The results are summarized 
in Figure 6 in Appendix.  A preliminary examination of the data revealed no significant change 
in these gold-standard measures, so the examination was deferred for the other formant 
measurement methods. 
VFDc.  The vector lengths for each of the corner vowels /i/, /u/, /æ/, and /ɑ/ were 
calculated using the formant measurement methods HGIM, LPCf, ceps, and S-B.  These lengths 
were then averaged to yield an average vector length for the vowel space for each trial, PRE1, 
PRE2, POST1, and POST2.  These values were then graphed in the same manner described 




the lettered set representing the different formant measurement methods.  Visual inspection 
revealed no general trend of increase or decrease across treatment.  By visual inspection of the 
data, treatment effects did not appear to be any larger than trial-to-trial variability.   Individual 
increases or decreases across treatment did not appear to exceed increases or decreases across 
trials.   
Numerical Presentation of Findings 
The results were also summarized numerically to corroborate the graphical results.  To 
determine whether treatment effects exceeded trial variability in this regard, the ranges of the pre 
and post-trial differences and the treatment differences were calculated for each metric and 
organized by formant measurement method.  The ranges of the pretrial differences were 
determining by calculating the subtracting the PRE1 metric value from the PRE2 metric value 
for each subject.  The pretrial differences were ordered numerically to determine the minimum 
and maximum and the range was calculated by subtracting the minimum from the maximum.  
The same process was repeated for the post trial difference range.  Treatment differences were 
computed by subtracting the PRE2 values from the POST1 values, since this difference could 
most reasonably be expected to show treatment effects.  These differences were then ordered 
numerically and the range was calculated by subtracting the minimum from the maximum. 
Results are summarized in Table 4 in Appendix.   
A review of Table 4 shows that the treatment range exceeded the pre and post-trial ranges 
for all metrics when calculated using HGIM.  The treatment range did not exceed the trial ranges 
for any metric using LPCf.  For ceps, only VFDa and VFDc had treatment ranges that exceeded 
the trial ranges.  The area of the vowel quadrilateral and VFDc calculated using S-B had 




the trial ranges, the treatment ranges were not substantially larger than the trial differences.  This 
supports the initial conclusion that treatment effects did not significantly exceed trial differences. 
While Table 4 provides information on trial variability versus treatment differences, it 
gives very little information about the direction and magnitude of treatment differences.  To 
determine whether any appreciable increases or decreases were observed from pre to post 
treatment, the means for each vowel space metric were computed both pre and post therapy.  The 
means for the pre vowel spaces were computed by averaging the vowel spaces across subjects 
for both the PRE1 and PRE2 sessions.  This was repeated for the average post vowel spaces.  
The mean difference was computed by subtracting the average pre vowel space from the average 
post vowel space.  The results are summarized in Table 5. 
 An examination of Table 5 supports the initial conclusion that the average post vowel 
space values did not appreciably exceed the average pre vowel space values.  A slight decrease 
was noted for all vowel spaces calculated using HGIM except for F2i/F2u which showed no 
change.  For LPCf, VAI, F2i/F2u and the area of the vowel quadrilateral all showed a slight 
decrease while VFDa and VFDc showed a moderate increase.  For ceps, VAI showed a slight 
decrease, F2i/F2u showed no change.  Slight increases in the area of the vowel quadrilateral, 
VFDa, and VFDc were noted for ceps.  All vowel spaces calculated using S-B decreased slightly, 
except F2i/F2u which showed no change.  
Findings in Formant Measurement Methods 
 A central question in this study was whether phonatory factors influenced formant 
measurement methods.  Such an influence could potentially skew VSA measures, regardless of 
metric used.  Failure of this study to find significant changes in vowel space following LSVT 




phonatory factors.  LPC was of particular interest because of its common use in previous VSA 
studies, and its anticipated vulnerabilities to phonatory factors.  It was expected that, if phonatory 
factors were a confounding factor, there would be a high level of variability in the pre-treatment 
sessions that decreased in the post-treatment sessions.  It was conjectured that the measures 
would be relatively more stable in the post condition due to the previously established phonatory 
improvements that accompany LSVT.   
To investigate this possibility, the standard deviations of each metric in the pre and post 
condition were calculated and organized by formant measurement method.  Results are 
summarized in Appendix.  Of all the formant measurement methods, LPCf had the greatest 
standard deviation in both pre- and post-treatment sessions.  Contrary to expectations, however, 
the standard deviation of pre and post-trial differences saw no stabilization of LPCf.  HGIM, 
ceps, and S-B had relatively similar standard deviations and did not show a significant change 
from pre to post.  Therefore, the conjecture that measurement issues were confounded with 
phonatory factors in previous findings of vowel space increase with LSVT was not supported.  
Discussion 
LSVT Treatment Effects 
The initial premise of this thesis was that VSA would increase from pre to post LSVT.  
However, the data do not support that there is any substantial change in VSA with LSVT.  There 
are many possible reasons why this study failed to replicate the results found by Sapir et al. 
(2010).  LPC was found to have the highest variability of all the formant measurement methods 
examined in this study, and so prior results may have been affected by this variability.  The 
difference in materials used may also have influenced the results.  The study by Sapir et al. 




there is the tenuous possibility that the shorter phrases yielded larger VSAs in the pre sessions, 
leaving little room for improvement as a result of LSVT.  Sapir et al.’s (2010) study included a 
larger number of participants (19) than the current study but reported large effect sizes for the 
formant centralization ratio (the inverse of VAI) and F2i/F2u.  Therefore it does not appear the 
difference in number of participants fully accounts for this study’s failure to replicate previous 
results.  Additionally, the treatment in this study was a combination of LSVT and transcranial 
magnetic stimulation (TMS), while Sapir et al.’s (2010) study utilized LSVT only.  Since the 
researchers in this study are still blinded as to which participants received TMS versus sham 
TMS, it is unknown if the addition of TMS had any effect on vowel space that would not have 
been observed in Sapir et al.’s (2010) study.  The current study also utilized the LSVT 
Companion (Halpern et al., 2012), while Sapir et al. (2010) did not.  Therapy supported by the 
LSVT Companion has been shown to be comparable to traditional face-to face therapy.   
 To determine whether there was a common factor between subjects who did show an 
increase in vowel space area following LSVT, two subjects were examined.  Subjects 1 and 4, 
showed a consistent increase across many, but not all, of the VSA metrics as based on all 
measurement methods.  Subject 4 showed a stronger tendency to increase, with a very slight 
decrease in the area of the vowel quadrilateral as calculated by HGIM and LPCf.  She was noted 
to consistently demonstrate the largest vowel space across methods, metrics, and pre- vs. post-
treatment sessions.  Though Subject 1’s increases were generally weaker than Subjects 4’s, he 
did show consistent increases across all metrics and methods except for VAI calculated with 
LPCf, and the F2i/F2u ratio calculated with LPCf.  In both these exceptions, the decrease was 
noted to be very slight.  In contrast to Subject 4 however, Subject 1 was noted to be on the lower 




are some people for whom LSVT does lead to an increase in VSA, though it is difficult to 
conclude whether a common factor led to increased VSA in these participants and not the others. 
To determine how specific vowels were affected in Subjects 1 and 4, the individual 
vowel vector lengths were examined. Figure 7 in Appendix shows the pre to post change in 
vector lengths for each vowel for Subjects 1 and 4.    Subject 4 showed moderate increases in 
/æ/, /i/, and /u/ and a slight decrease in /ɑ/ while remaining approximately the same for /ɛ/ and 
/ʌ/.  Overall, the data support the observation of a modest increase in VSA for Subject 4.  
Specifically, the vectors for the front vowels /i/ and /æ/ increased suggesting more forward 
positioning of the tongue post-treatment.  Additionally, the expansion of /i/ and /u/ as high 
vowels and /æ/ as a low vowel support the notion of greater range in the size of oral constriction. 
Subject 1 showed moderate vector length increases for /æ/, /i/, and /u/ and moderate decreases 
for /ɑ/, /ʌ/.  The vector length of /ɛ/ remained approximately the same.  The decrease in vector 
length for /ɑ/ may explain why he showed weaker increases in the various VSA metrics than 
Subject 4.  Based on the results of at least these two subjects, it is possible that /i/ and /u/ are the 
vowels most likely to benefit from LSVT, explaining why VSA metrics that include these two 
vowels are more likely to show increases than those that employ others. 
Since Table 4 showed that most vowel space metrics had a greater treatment range than 
trial range, this may initially lead to the mistaken impression that a substantial change due to 
treatment took place.  However, since Table 4 only includes the range of treatment differences, it 
cannot be used to make conclusions about direction or magnitude of overall treatment effects.  
The wider range seen in treatment differences versus pre and post-trial ranges can be accounted 
for by the fact that some participants showed an increase in vowel space metric values while 




participants varied widely in the magnitude and direction of changes over treatment.  A better 
measure of treatment effects is Table 5, which summarizes the mean pre and post vowel space 
metric values, and the signed difference of these averages.  Table 5 shows that changes in vowel 
space metric values varied slightly in most cases and that the direction of this change was also 
inconsistent and highly influenced by the formant measurement method.  The only metrics that 
showed a moderate increase were VFDa and VFDc calculated using LPCf.  This change can 
most likely be accounted for by the wide variability associated with LPCf. 
Formant Measurement Methods 
The possible influence of phonatory factors on the various formant measurement methods 
was a question of interest in this study.  If LPC were influenced by phonatory factors, it was 
expected that LPC with a fixed coefficient (LPCf) would be relatively more stable in the post 
condition.  By contrast, ceps and S-B, theoretically independent of phonatory factors, were 
hypothesized to yield formants that were closer to HGIM.  LPC was not found to be more stable 
in the post condition as the standard deviation of the trial differences did not appear to decrease 
from the pre to post condition (see Table 5 in Appendix).  Therefore LPC is likely not influenced 
so much by phonatory factors as initially supposed. However, LPCf was noted to have a greater 
variability than any of the other measures, implying that it was the least stable of the four 
measurement methods explored.  The variability of ceps and S-B were comparable to those of 
HGIM, tentatively supporting the claim that ceps and S-B are uninfluenced by phonatory factors.   
 Another methodological goal of this thesis was to examine the potential errors associated 
with keeping LPC at a fixed coefficient based on the sampling rate.  In this study, LPCf was 
found to have misidentified the appropriate formant on 35 occasions and to have merged 




In the course of the investigation, it was noted that these errors were not evenly distributed 
across vowels.  This was of potential importance due to the reliance of some vowel space metrics 
on a limited set of vowels.  The vowels most prone to formant misidentification were /u/ and /ɑ/, 
while the vowel most likely to suffer from formant merging was /i/.  Formant were misidentified 
in /u/ on 15 out of 80 instances, or 18.8% of the time.  Formant were misidentified in /ɑ/ on 13 
out of 80 occasions, or 16.3% of the time.  Formants were misidentified or merged 14 out of 80 
times for the vowel /i/, or 17.5% of the time.  A complete breakdown of errors by vowel can be 
found in Table 7 in Appendix.  Overall, the errors associated with LPCf were generally 
concentrated in the vowels /i/, /u/, and /ɑ/.  This is especially important because these vowels are 
the ones most typically associated with VSA metrics, including the vowel articulation index 
(VAI), F2i/F2u, and area of the vowel quadrilateral.  Several metrics, such as VAI and F2i/F2u, 
rely solely on these vowels.  Inaccuracy in the measurement of these formants can lead to 
inaccurate VSA values.  
 LPC was not the only formant measurement method prone to errors in correct formant 
identification.  To appropriately locate and differentiate formants, it was often necessary to 
adjust the two cepstrally-liftered spectrum methods, ceps and S-B, by adjusting the time-based 
liftering coefficient.   Both ceps and S-B were most prone to error in the form of merged 
formants on the vowels /i/ and /ɑ/.  Since adjustment could generally resolve this issue, both ceps 
and S-B appear to have value as a guide for formant location in conjunction with other methods.  
However, based on the prevalence of errors in LPC, ceps and S-B, it is not appropriate to use any 
of these methods as an automated formant finder and human judgment is indispensable in 
accurate formant location. 




replicate the results of previous studies, this study calls into question claims that LSVT leads to 
increased vowel space.  This study has raised a variety of methodological questions and 
highlighted the importance of thoughtful selection of VSA metric and formant analysis.  
Automated formant measurement methods are prone to significant error that can lead to 
erroneous results.  It is clear that further study is required to understand what—if anything—is 
occurring in the area of vowel articulation as a result of LSVT. 
Areas of Further Study 
 One area of further study that could be addressed is changes in F1 and F2 for individual 
vowels as a result of LSVT.  Since all VSA metrics, with the exception of F2i/F2u, utilized both 
F1 and F2, it is possible that important information about the individual formants was lost.  
Further analysis of the data to explore changes in individual formants could reveal a general 
trend of expansion in one dimension that was mitigated by lack of change in the other.  It would 
also be interesting to compare the changes in vowel space observed in this study with other 
acoustic measures such as changes in loudness and perceptual measures such as changes in voice 
quality.  This might help shed light on why some participants, such as Subjects 1 and 4, showed 
a general increase in vowel space while others did not.  Since this study utilized TMS in addition 
to LSVT, the revelation of which participants received TMS versus sham TMS might also clarify 
how TMS impacted the efficacy of therapy.   
The three-month follow-up sessions could also be analyzed, though their value is 
questionable in light of this study’s apparent failure to find treatment effects.  Another area of 
interest would be to replicate this study with read sentences instead of carrier phrases to more 
closely replicate the study by Sapir et al. (2010) to control for possible ceiling effects introduced 




significant error in formant measurement, it would be valuable to know how well LPC adjusted 
to fit the spectrum would agree with HGIM.  Answers to these questions would go a long way to 
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Vowel Space Metrics 
Measure Algorithm Citation Task Notes 
Area of vowel 
quadrilateral 
 
Area of an irregular quadrilateral = 0.5 × ([𝐹𝐹2𝑖𝑖 × 𝐹𝐹1æ +
𝐹𝐹2æ × 𝐹𝐹1𝑎𝑎 + 𝐹𝐹2𝑎𝑎 × 𝐹𝐹1𝑢𝑢 + 𝐹𝐹2𝑢𝑢 × 𝐹𝐹1𝑖𝑖] − [𝐹𝐹1𝑖𝑖 × 𝐹𝐹2æ +



































�𝐿𝐿𝐿𝐿𝐿𝐿 × (𝐿𝐿𝐿𝐿𝐿𝐿 − 𝐿𝐿𝐿𝐿𝐿𝐿𝐿𝐿𝑖𝑖𝑢𝑢)(𝐿𝐿𝐿𝐿𝐿𝐿 − 𝐿𝐿𝐿𝐿𝐿𝐿𝐿𝐿𝑖𝑖𝑎𝑎)(𝐿𝐿𝐿𝐿𝐿𝐿 − 𝐿𝐿𝐿𝐿𝐿𝐿𝐿𝐿𝑎𝑎𝑢𝑢) 
Where 𝐿𝐿𝐿𝐿𝐿𝐿𝐿𝐿𝑖𝑖𝑢𝑢 = �(𝐿𝐿𝐿𝐿𝐹𝐹1𝑖𝑖 − 𝐿𝐿𝐿𝐿𝐹𝐹1𝑢𝑢)2 + (𝐿𝐿𝐿𝐿𝐹𝐹2𝑖𝑖 − 𝐹𝐹2𝑢𝑢)2 
             𝐿𝐿𝐿𝐿𝐿𝐿𝐿𝐿𝑖𝑖𝑎𝑎 = �(𝐿𝐿𝐿𝐿𝐹𝐹1𝑖𝑖 − 𝐿𝐿𝐿𝐿𝐹𝐹1𝑎𝑎)2 + (𝐿𝐿𝐿𝐿𝐹𝐹2𝑖𝑖 − 𝐹𝐹2𝑎𝑎)2 
          𝐿𝐿𝐿𝐿𝐿𝐿𝐿𝐿𝑎𝑎𝑢𝑢 = �(𝐿𝐿𝐿𝐿𝐹𝐹1𝑎𝑎 − 𝐿𝐿𝐿𝐿𝐹𝐹1𝑢𝑢)2 + (𝐿𝐿𝐿𝐿𝐹𝐹2𝑎𝑎 − 𝐹𝐹2𝑢𝑢)2 




















Table 1 (Continued) 
Vowel Space Metrics 
Measure Algorithm Citation Task Notes 



























individuals with PD 
and healthy controls; 




Bisecting vowel quadrilateral into two triangles, 
calculating area of each triangle, and summing 


















area for participants 




area for participants 






0.5 × ([𝐹𝐹2𝑢𝑢 + 𝐹𝐹2𝑖𝑖] × [𝐹𝐹1𝑢𝑢 − 𝐹𝐹1𝑖𝑖] − [𝐹𝐹2𝑎𝑎 + 𝐹𝐹2𝑢𝑢] ×
[𝐹𝐹1𝑎𝑎 − 𝐹𝐹1𝑢𝑢] − [𝐹𝐹2𝑎𝑎 + 𝐹𝐹2𝑖𝑖] × [𝐹𝐹1𝑎𝑎 − 𝐹𝐹1𝑖𝑖])  
Bradlow, 
Torretta, & Pisoni 
(1996) 
 








No positive correlation 
between tVSA and 
intelligibility in normal 
speakers. 
 






Table 1 (Continued) 
Vowel Space Metrics 





𝐹𝐹1𝑖𝑖 + 𝐹𝐹1𝑢𝑢 + 𝐹𝐹2𝑢𝑢 + 𝐹𝐹2𝑎𝑎
 




Reduced values in male 
and female PD 
speakers; more 
sensitive to mild 





Vector length=�(𝐹𝐹1−𝐹𝐹1𝑚𝑚)2+(𝐹𝐹2 − 𝐹𝐹2𝑤𝑤𝑚𝑚)2 
Where F1m is the average of all F1 tokens and F2wm is 
the weighted average of all F2 tokens such that all F2 
tokens associated with F1 values greater than F1m are 
excluded. 




In normal speakers, 
VFD less prone to 
producing Type I or 
Type II errors than 
VAI, FCR, and other 
vowel space metrics 
Vowel Space 











participants with PD 
and neurologically 




Vector length=�(𝐹𝐹1−𝐹𝐹1𝑚𝑚)2+(𝐹𝐹2 − 𝐹𝐹2𝑚𝑚)2 
Where F1m is the average of all F1 tokens and F2m is 
the average of all F2 tokens.  Vector lengths are 
averaged to yield a single number  
Bradlow, 













Summary of Reliability Data Organized According to Formant Measurement Method and 
Formant 
 
 HGIM  LPCf  Ceps  Ceps S-B 
 F1 F2  F1 F2  F1 F2  F1 F2 
Pearson’s r 0.93 0.96  0.93 0.90  0.80 0.94  0.89 0.96 
Average 
difference -20.88 -15.70 
 5.70 -3.18  6.21 -56.50  2.49 -45.18 
Standard 
error diffs 5.95 13.16 
 5.28 21.85  9.37 17.53  7.22 14.12 
Table 2 
Additional Exclusion Criteria 
History of drug abuse, neurological condition besides IPD, seizures, head trauma 
Other current medical conditions, including brain damage, brain inflammation, heart disease, 
pregnancy, uncorrected hearing loss 
Medical implants, including metal objects implanted in head, ferrous metal filings in eye, 
pacemaker, medication pump, cardiac lines 
Current medications, including certain medications for depression or seizures 
Advanced Parkinson’s Disease (stage V) 
Score of greater than 19 on the Beck Depression Inventory 
Score of less than 24 on Mini-Mental Status Examination 
Have undergone LSVT within the last three years 
Cannot read at 6th grade level 






Range of Pre- and Post-trial Differences versus Treatment Differences 
 HGIM LPC fixed  Ceps  Ceps S-B 
 Pre Post Tx  Pre Post Tx  Pre Post Tx  Pre Post Tx 
VAI 0.16 0.09 0.20  0.34 0.33 0.33  0.15 0.21 0.13  0.19 0.14 0.16 
F2i/F2u 0.48 0.36 0.51  0.82 1.08 0.99  0.42 0.78 0.35  0.52 0.44 0.40 
Area* 17.5 12.4 20.2  68.1 35.6 48.7  10.1 22.9 15.7  10.9 16.2 19.0 
VFDc 126.0 89.3 149.4  405.6 137.0 192.3  143.7 100.0 153.3  139.6 109.1 155.0 
VFDa 106.2 114.0 155.5  310.9 325.9 212.2  123.5 84.6 138.9  182.1 76.1 152.0 







Pre- and Post- Mean Values versus Mean Difference 
 HGIM  LPC fixed  Ceps  Ceps S-B 
 Pre Post Diff  Pre Post Diff  Pre Post Diff  Pre Post Diff 
VAI 1.08 1.05 -0.03  1.06 1.01 -0.04  1.08 1.07 -0.01  1.08 1.06 -0.02 
F2i/F2u 1.74 1.74 0.00  1.61 1.56 -0.05  1.77 1.77 0.00  1.79 1.79 0.00 
Area* 24.2 22.5 -1.6  18.3 18.1 -0.2  22.4 22.7 0.2  24.1 23.2 -0.9 
VFDc 454.0 448.5 -5.5  504.4 527.8 23.4  470.3 475.7 5.4  478.9 477.5 -1.5 
VFDa 400.3 392.1 -8.3  445.1 483.9 38.9  400.0 407.3 7.3  420.2 418.4 -1.8 






Standard Deviation of Trial Differences 
 HGIM LPC fixed Ceps Ceps S-B 
 Pre Post Pre Post Pre Post Pre Post 
VAI 0.05 0.03 0.10 0.12 0.04 0.05 0.05 0.04 
F2i/F2u 0.14 0.12 0.25 0.37 0.12 0.21 0.13 0.12 
Area* 5.4 3.6 18.0 11.7 3.7 5.8 4.4 4.6 
VFDc 38.69 26.74 108.29 51.73 39.97 32.54 38.95 31.86 
VFDa 31.83 31.73 87.69 88.56 37.71 28.48 47.20 30.67 
* × 104 
 Table 7 
Incidence of LPC Formant Identification Errors 
 ɛ ʌ u i æ ɑ 
Formants missed 0 4 15 3 0 13 
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Figure 1a. VAI calculated using HGIM as a function of treatment and trial differences 
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Figure 1c. VAI calculated using ceps as a function of treatment and trial differences 
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Figure 2a. F2i/F2u calculated using HGIM as a function of treatment and trial differences 
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           Pre         Post 
                             
Figure 2c.  F2i/F2u calculated using ceps as a function of treatment and trial differences 
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Figure 2d.  F2i/F2u calculated using S-B as a function of treatment and trial differences 
 




              
Figure 3a.  Area of vowel quadrilateral calculated using HGIM as a function of treatment and trial differences 
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Figure 3c.  Area of vowel quadrilateral calculated using ceps as a function of treatment and trial differences 
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Figure 4a.  VFDa calculated using HGIM as a function of treatment and trial differences 
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Figure 4c.  VFDa calculated using ceps as a function of treatment and trial differences 
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Figure 5a.  VFDc calculated using HGIM as a function of treatment and trial differences 
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Figure 5c.  VFDc calculated using ceps as a function of treatment and trial differences 
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Figure 6.  Comparison of pre to post LSVT vector lengths calculated using VFDa 
 
    Subject 1     Subject 4 
 
Figure 7.  Comparison of pre to post LSVT vector lengths calculated using VFDa in Subjects 1 
and 4 
 
From: Beverly Jacobik (bjacobik) On Behalf Of Institutional Review Board 
Sent: Wednesday, October 01, 2014 9:15 AM 
To: Michael P Cannito (mcannito) 
Subject: IRB Approval 3429 
Hello, 
The University of Memphis Institutional Review Board, FWA00006815, has reviewed and 
approved your submission in accordance with all applicable statuses and regulations as well as 
ethical principles. 
PI NAME: Michael Cannito 
CO-PI: Shalini, Narayana, Ph.D., Asim F. Choudhri, MD, Ronald F. Pfeiffer, MD, at UTHSC 
PROJECT TITLE: Augmenting Treatment Effects of Voice Therapy in Parkinson’s Disease 
FACULTY ADVISOR NAME (if applicable): n/a 
IRB ID: #3429 
APPROVAL DATE: 9/11/2014      
EXPIRATION DATE: 8/6/2015 
LEVEL OF REVIEW: Facilitated Review, UTHSC 
RISK LEVEL DETERMINATION:No more than minimal 
Please Note: Modifications do not extend the expiration of the original approval 
Approval of this project is given with the following obligations: 
1. If this IRB approval has an expiration date, an approved renewal must be in effect to
continue the project prior to that date. If approval is not obtained, the human consent
form(s) and recruiting material(s) are no longer valid and any research activities involving
human subjects must stop.
2. When the project is finished or terminated, a completion form must be completed and
sent to the board.
3. No change may be made in the approved protocol without prior board approval,
whether the approved protocol was reviewed at the Exempt, Exedited or Full Board level.
4. Exempt approval are considered to have no expiration date and no further review is
necessary unless the protocol needs modification.
Approval of this project is given with the following special obligations: 
Pamela M. Valentine 
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Interim Institutional Review Board Chair 
The University of Memphis. 
Note: Review outcomes will be communicated to the email address on file. This email should 
be considered an official communication from the UM IRB. Consent Forms are no longer 
being stamped as well. Please contact the IRB at IRB@memphis.edu if a letter on IRB 
letterhead is required. 
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THE UNIVERSITY OF TENNESSEE 
Health Science Center 
Institutional Review Board 
910 Madison Avenue, Suite 600 
Memphis, TN 38163 
Tel: (901) 448-4824 
5 August 2015    
Shalini Narayana, PhD 
UTHSC - COM - Peds - General Pediatrics 
335 Le Bonheur Outpatient Center 
51 N Dunlap Street 
Memphis, TN 38105 
Re:  14-03265-FB UM 
Study Title:  Augmenting Treatment Effects of Voice Therapy in Parkinson's Disease [Master 
Protocol, dated 01/15/2014; revised 06/05/2015] 
Dear Dr. Narayana: 
On 08/05/2015, the UTHSC Institutional Review Board (IRB) reviewed your application to 
continue your previously approved project, referenced above.  The IRB has reviewed your 
renewal application and determined that it complies with proper consideration for the rights and 
welfare of human subjects and the regulatory requirements for the protection of human subjects.  
Therefore, this letter constitutes approval of your renewal application, including main and 
repository consent forms dated 07/07/2015 (stamped IRB approved 08/05/2015).  The UTHSC 
IRB stamped-approved consent forms must be used to enroll prospective subjects in the 
study.  Approval of this study will be valid from 08/05/2015 to 08/06/2016. 
This study may not be continued until you receive re-approval from the institution(s) where 
the research is being conducted. 
In accord with 45 CFR 46.116(d), alteration of informed consent continues to be approved, with 
the cover statement for telephone screening used in lieu of an informed consent interview.  The 
requirement to secure a signed consent form continues to be waived under 45 CFR 46.117(c)(2).  
Willingness of the subject to participate constitutes adequate documentation of consent. 
In addition, the request for waiver of HIPAA authorization to identify potential subjects for 
recruitment continues to be approved.  The waiver applies to the medical records of patients with 
Parkinson’s disease from referring physicians and local support groups. 
In the event that subjects are to be recruited using solicitation materials, such as brochures, 
posters, web-based advertisements, etc., these materials must receive prior approval of the IRB.  
Any revisions in the approved application must also be submitted to and approved by the IRB 
prior to implementation.  In addition, you are responsible for reporting any unanticipated serious 
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adverse events or other problems involving risks to subject or others in the manner required by 
the local IRB policy.   
Finally, re-approval of your project is required by the IRB in accord with the conditions 
specified above.  You may not continue the research study beyond the time or other limits 
specified unless you obtain prior written approval of the IRB.  
Sincerely, 
Signature applied by Holly A Herron  on 08/05/2015 11:34:43 AM CDT 
Holly A Herron, BA, CIM Terrence F Ackerman, PhD 
IRB Administrator  Chairman 
UTHSC IRB UTHSC IRB 
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THE UNIVERSITY OF TENNESSEE 
Health Science Center 
Institutional Review Board 
910 Madison Avenue, Suite 600 
Memphis, TN 38163 
Tel: (901) 448-4824 
September 11, 2014 
Shalini Narayana, PhD 
UTHSC - COM - Peds - General Pediatrics 
335 Le Bonheur Outpatient Center 
51 N. Dunlap Street 
Memphis, TN 38105 
Re:  14-03265-FB UM 
Study Title:  Augmenting Treatment Effects of Voice Therapy in Parkinson's Disease [Master 
Protocol, dated 1/15/2014] 
Dear Dr. Narayana: 
The IRB has received your written acceptance of and/or responses dated 09/10/2014 and 9/9/2014 
to the provisos outlined in our correspondence of 9/10/2014 and 8/6/2014 concerning the 
application for the above referenced project.  The IRB has reviewed these materials and 
determined that they comply with proper consideration for the rights and welfare of human 
subjects and the regulatory requirements for the protection of human subjects.  Therefore, this 
letter constitutes full approval by the IRB of your application, Version 1.5 and the accompanying 
documents:  
 Master Protocol, dated 1/15/2014
 510K document, dated 9/29/2011
 Charite Clinical Statement, dated 10/31/2012
 Navigated Brain Stimulation Product Brochure, Version 1.0
 NexSpeech for NBS System Product Brochure, Version 1.0
 Flyer, dated 9/11/2014 (stamped IRB approved 9/11/2014)
 Recruitment Brochure, dated 9/9/2014 (stamped IRB approved 9/11/2014)
 Phone screening form, dated 9/9/2014
 Voice-related QOL, dated 6/10/2014 (stamped IRB approved 9/11/2014)
 Subject Information Sheet, dated 6/10/2014 (stamped IRB approved 9/11/2014)
 Screening Questionnaire for TMS Candidates-SN, dated 6/10/214 (stamped IRB approved
9/11/2014)
 MRI-TMS Metal Screening, dated 6/10/2014 (stamped IRB approved 9/11/2014)
 Mini Mental State Exam, dated 6/10/2014
 Medical History Screening, dated 6/10/2014 (stamped IRB approved 9/11/2014)
 Edinburgh Handedness Inventory, dated 6/10/2014 (stamped IRB approved 9/11/2014)
 Beck Depression Inventory, dated 6/10/2014 (stamped IRB approved 9/11/2014)
 Main Consent form, dated 9/11/2014 (stamped IRB approved 9/11/2014)
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 Repository Consent Form, dated 9/11/2014 (stamped IRB approved 9/11/2014)
Approval of this study will be valid from 9/11/2014 to 8/6/2015. 
This study may not be initiated until you receive approval from the institution(s) where the 
research is being conducted. 
The IRB has determined that the informed consent form, incorporating the authorization of 
subjects to use their protected health information in research, complies with the federal privacy 
regulations as specified in 45 CFR 160 and 45 CFR 164.  In addition, in accord with 45 CFR 
46.116(d), informed consent may be altered, with the cover statement of the telephone screening 
used in lieu of an informed consent interview.  The requirement to secure a signed consent form 
is waived under 45 CFR 46.117(c)(2).  Willingness of the subject to participate will constitute 
adequate documentation of consent. 
In addition, the request for waiver of HIPAA authorization for telephone screening is approved. 
The waiver applies to the medical records of Parkinson’s Disease patients.  
In the event that subjects are to be recruited using solicitation materials, such as brochures, 
posters, web-based advertisements, etc., these materials must receive prior approval of the IRB. 
Any revisions in the approved application must also be submitted to and approved by the IRB 
prior to implementation.  In addition, you are responsible for reporting any unanticipated serious 
adverse events or other problems involving risks to subjects or others in the manner required by 
the local IRB policy.   
Finally, re-approval of your project is required by the IRB in accord with the conditions 
specified above.  You may not continue the research study beyond the time or other limits 
specified unless you obtain prior written approval of the IRB.  
Sincerely, 
Signature applied by Margaret M Sularin  on 09/11/2014 09:29:33 AM CDT 
Signature applied by Terrence F Ackerman  on 09/11/2014 09:33:35 AM CDT 
Margaret M. Sularin, LMSW, RD, LDN, CCRP, CIM Terrence F. Ackerman, Ph.D. 
Regulatory Specialist Chairman 
UTHSC IRB UTHSC IRB 
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